Drug survival in psoriatic patients treated with biologic agent for the first time - 11/08/17
Marianna Mitratza, MD, University of Athens, Medical School, Department of Epidemiology and Biostatistics; Evangelia Papadavid, MD, University of Athens, Medical School, Attikon University Hospital, 2nd Dermatology Department; Christina Bamia, PhD, University of Athens, Medical School, Department of Epidemiology and Biostatistics; Konstantinos Theodoropoulos, MD, University of Athens, Medical School, Attikon University Hospital, 2nd Dermatology Department; Pelagia Katsimbri, MD, University of Athens Medical School, Attikon University Hospital, Department of Internal Medicine; Dimitrios Boumbas, MD, University of Athens, Medical School, Attikon University Hospital, 2nd Dermatology Department; Dimitrios Rigopoulos, MD, University of Athens, Medical School, Attikon University Hospital, 2nd Dermatology Department
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 76 - N° 6S1
P. AB106 - juin 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?